Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
N6-methyladenosine (m6A) modification is the most abundant modification in long noncoding RNAs (lncRNAs). Current studies have shown that the abnormal expression of m6A-related genes is closely associated with the tumorigenesis and progression of glioma. However, the role of m6A-related lncRNAs in g...
Main Authors: | Yujia Chen, Yuduo Guo, Shenglun Li, Jiacheng Xu, Xiang Wang, Weihai Ning, Lixin Ma, Yanming Qu, Mingshan Zhang, Hongwei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.789283/full |
Similar Items
-
Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas
by: Shenglun Li, et al.
Published: (2023-08-01) -
N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
by: Di Zheng, et al.
Published: (2022-02-01) -
Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
by: Xin Huang, et al.
Published: (2022-08-01) -
Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
by: Danjun Song, et al.
Published: (2023-03-01) -
The functions of N6-methyladenosine modification in lncRNAs
by: Rong-Zhang He, et al.
Published: (2020-12-01)